Director, Portfolio Insights - Therapeutic Area Lead

Company Description

AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas – immunology, oncology, neuroscience, and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on X, Facebook, Instagram, YouTube, LinkedIn and Tik Tok.

Job Description

The Portfolio Insights team is responsible for enabling AbbVie to make data-driven decisions on portfolio choices both within and across Therapeutic Areas (TAs). Portfolio Insights TA leads provide analytics and recommendations to drive better decision-making across the internal portfolio and BD opportunities on a project and TA-level.

The Director, Portfolio Insights - TA Lead acts as the voice of Portfolio Insights for their Therapeutic Areas. They will be responsible for presenting and defending recommendations for Therapeutic Area leadership and driving the analytics and co-ordination of inputs across functions to deliver high quality insights.  

Responsibilities:

• Deliver high-impact recommendations for their Therapeutic Areas on project value, trade-offs and scenarios to senior leadership within TAs and in AbbVie governance forums.
• Proactively identify opportunities where valuation and economic analysis can drive higher quality decision making for asset strategy teams and TAs.
• Build value metrics (e.g., raNPV, PI) and any required scenario analysis to drive effective drug development decisions, working with ASLs (asset strategy leaders), Search & Evaluation (S&E), program managers, pipeline commercial leads, forecasting teams and others.
• Coach team members on valuations, economic analysis and best practices for data-driven decision-making.
• Provide an unbiased assessment of PTRS (probability of technical and regulatory success) for drug development projects, working with clinical development and regulatory teams.
• Recommend TA-level prioritization of projects within their therapeutic areas, working with TA leadership and members of the p